Maze Therapeutics has revealed topline phase 2 data for its lead kidney disease candidate that has analysts heralding its “best-in-class potential.” The once-daily oral small molecule APOL1 inhibitor, ...

John Steinbach was shocked to receive a $281 electricity bill in January 2026—a huge spike from the roughly $100 he’d paid the previous month. “It’s just so far beyond any bill that I’ve ever had,” he ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Man analyzes stock during morning trading. Data center stocks are part of a rapidly growing ...

Anthropic's massive revenue growth means more spending at Amazon's AWS. AWS' revenue is already accelerating and should continue to grow for many years. AWS' earnings power within a few years will ...

Most of the world's information is stored digitally right now. Every year, we generate more data than we did the year before. Now, with AI in the picture, a technology that relies on a whole lot of ...

The San Francisco start-up claimed that DeepSeek, Moonshot and MiniMax used approximately 24,000 fraudulent accounts to train their own chatbots. By Cade Metz Reporting from San Francisco The San ...

Medical free texts such as pathology reports contain valuable clinical data but are challenging to structure at scale. Traditional natural language processing approaches require extensive annotated ...

U.S. stocks have given up all of their gains for the year, a key index of the so-called Magnificent Seven tech giants has slid into correction territory, and volatility gauges have spiked amid a ...

Shares of Generac Holdings shot up toward a multiyear high on Wednesday, after the maker of home generators provided an upbeat sales-growth outlook as the company’s push into the data-center market ...

It won't surprise readers to know that its data center solutions boomed in 2025. Even though they only grew 4% quarter over quarter (QoQ), they increased 101% year over year (YoY), driven by ongoing ...

Evommune has aced its first major test as a public company, reporting phase 2a eczema data that caused its share price to jump 75% in premarket trading. The biotech, which went public late last year, ...

Starlink says it may also share personal data with partners to help it "develop AI-enabled tools that improve your customer experience.” Joe Supan is a senior writer for CNET covering home technology, ...